1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

Tuberculosis is one of the fetal diseases, which is complex to treat. The bacteria responsible for this disease are Mycobacterium tuberculosis. It is able to hide from antibiotics inside the immune cells that are supposed to kill them. T...

Read More

---

Simvastatin – A New Approach to prevent Ischemic Damage Of Heart During Organ Transplant

Release Date: 25 September 2019

According to the author of the study Antti I. Nykanen, A single dose of the simvastatin, which is able to lower the level of lipids in body, delivered to an organ donor pre-heart transplant, could decrease postoperative troponin lev...

Read More

---

More Accurate Drug Delivery can be Achieved with Graphene Nanoflakes

Release Date: 25 September 2019

A new compound is recently created by the Chemists funded by Swiss National Science Foundation, which is able to deliver the drug in a flexible way. This is able to effectively delivery the drug that targets the prostate cancer cells. In...

Read More

---

Targeted Drug Delivery can be Achieved by Nanoscale Glass Bottles

Release Date: 25 September 2019

A new drug delivery method for achieving target drug delivery involves use of small silica bottles. These bottles are filled with medicaments along with a special temperature sensitive material. This new device is able to deliver the dru...

Read More

---

Nanoparticle Advancement Shows Promising Action Against Prostate Cancer

Release Date: 24 September 2019

Prostate cancer is one of the leading cancers worldwide. About 11% men will face prostate cancer in their lifetime. Most of the traditional treatments such as chemotherapy, surgery and radiation can have fetal adverse effects. The Resear...

Read More

---

Darzalex – A New Approved Drug Combination For Multiple Myeloma

Release Date: 24 September 2019

The combination therapy has been become a most important part to treat various disorders as they involves multiple targeting on different receptors. This property is essential particularly in the treatment of multiple myeloma, which is a...

Read More

---

Phospho-specific Antibodies Are Introduced For Diagnosis

Release Date: 24 September 2019

Creative diagnosis introduces a newly developed phospho-specific antibodies for global scientists. Creative diagnosis is a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry. This newly de...

Read More

---

Newly Developed Peptide Shows Prominent Action Against Multidrug Resistant Bacteria

Release Date: 24 September 2019

A new peptide molecule is designed by the researchers of Indian Institute of Science (IISc), which is able to multi drug resistant bacterium called Acinetobactor baumannii. The safety and efficacy of this antimicrobial drug is very high,...

Read More

---

Liraglutide A Drug to Manage Pediatric Type 2 Diabetes

Release Date: 24 September 2019

A new study about the activity of the Liraglutide indicates that it is beneficial for glycemic control in children and adolescents with type 2 Diabetes Mellitus for up to a year. The trial involves the glucagon-like peptide-1 recept...

Read More

---

Neucardin got Fast Track Designation from US FDA for Chronic Heart Failure

Release Date: 24 September 2019

Neucardin is a product of Zensun USA, has received fast track designation from the food and drug administration (FDA) of US. This drug is able to target the heart and hence the designation is given for the use in chronic heart failure. T...

Read More

---

More Accurate Drug Delivery can be Achieved with Graphene Nanoflakes

Release Date: 23 September 2019

A new compound is recently created by the Chemists funded by Swiss National Science Foundation, which is able to deliver the drug in a flexible way. This is able to effectively delivery the drug that targets the prostate cancer cells. In...

Read More

---

Erdafitinib Effective Treatment of Advanced Bladder Cancer

Release Date: 23 September 2019

Erdafitinib is a drug belonging to the class of fibroblast growth factor receptor (FGFR) inhibition, shows promising action against the advanced urothelial carcinoma with alteration in the FGFR3 gene. This drug is available in the market...

Read More

---

Nivolumab-Ipilimumab Combination Shows Promising Activity in Advanced RCC Confirmed

Release Date: 23 September 2019

The Phase III clinical trial confirms that the survival benefit of nivolumab plus ipilimumab is more than the other first line treatment in patients with Read More

---

PD-L1 Checkpoint Inhibitors Indicates Activity against Aggressive MTC

Release Date: 23 September 2019

PD-L1’s association with the medullary thyroid cancer (MTC) is responsible for more aggressive clinicopathological features and also gives indication of structural and biochemical recurrences. This report was according to the resul...

Read More

---

CD8+ T Shows possibility in Treatment of SCLC

Release Date: 23 September 2019

The Phase II of clinical trial of immune checkpoint inhibitors gives a possibility of treatment of patients with small cell lung cancer (SCLC). The activity of combination of durvalumab and olaparib were observed in all the patients wher...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |